A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

NCT06906562 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Advanced Pancreatic Carcinoma
Metastatic Pancreatic Carcinoma
Stage II Pancreatic Cancer AJCC v8
Stage III Pancreatic Cancer AJCC v8
Stage IV Pancreatic Cancer AJCC v8

Interventions

DRUG: Pemigatinib
PROCEDURE: Computed Tomography (CT)
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Optical Coherence Tomography
PROCEDURE: Bone Scan
PROCEDURE: Ophthalmoscopy

Sponsor

Sameek Roychowdhury

Collaborators

[object Object]